CCPortal
DOI10.1126/science.abg9175
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Stamatatos L.; Czartoski J.; Wan Y.-H.; Homad L.J.; Rubin V.; Glantz H.; Neradilek M.; Seydoux E.; Jennewein M.F.; MacCamy A.J.; Feng J.; Mize G.; De Rosa S.C.; Finzi A.; Lemos M.P.; Cohen K.W.; Moodie Z.; McElrath M.J.; McGuire A.T.
发表日期2021
ISSN0036-8075
起始页码1413
结束页码1418
卷号372期号:6549
英文摘要Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have raised concerns about resistance to neutralizing antibodies elicited by previous infection or vaccination. We examined whether sera from recovered and naïve donors, collected before and after immunizations with existing messenger RNA (mRNA) vaccines, could neutralize the Wuhan-Hu-1 and B.1.351 variants. Prevaccination sera from recovered donors neutralized Wuhan-Hu-1 and sporadically neutralized B.1.351, but a single immunization boosted neutralizing titers against all variants and SARS-CoV-1 by up to 1000-fold. Neutralization was a result of antibodies targeting the receptor binding domain and was not boosted by a second immunization. Immunization of naïve donors also elicited cross-neutralizing responses but at lower titers. Our study highlights the importance of vaccinating both uninfected and previously infected persons to elicit cross-variant neutralizing antibodies. © 2021 American Association for the Advancement of Science. All rights reserved.
英文关键词SARS coronavirus
语种英语
来源期刊Science
文献类型期刊论文
条目标识符http://gcip.llas.ac.cn/handle/2XKMVOVA/245590
作者单位Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States; Department of Global Health, University of Washington, Seattle, WA, United States; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States; Centre de Recherche du CHUM, Montréal, QC, Canada; Département de Microbiologie Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada; Department of Medicine, University of Washington, Seattle, WA, United States
推荐引用方式
GB/T 7714
Stamatatos L.,Czartoski J.,Wan Y.-H.,et al. mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection[J],2021,372(6549).
APA Stamatatos L..,Czartoski J..,Wan Y.-H..,Homad L.J..,Rubin V..,...&McGuire A.T..(2021).mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.Science,372(6549).
MLA Stamatatos L.,et al."mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection".Science 372.6549(2021).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Stamatatos L.]的文章
[Czartoski J.]的文章
[Wan Y.-H.]的文章
百度学术
百度学术中相似的文章
[Stamatatos L.]的文章
[Czartoski J.]的文章
[Wan Y.-H.]的文章
必应学术
必应学术中相似的文章
[Stamatatos L.]的文章
[Czartoski J.]的文章
[Wan Y.-H.]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。